Xconomy

JULY 2, 2018

A paper published last week in the journal JAMA Oncology makes the case that one such test, Oncotype DX AR-V7 Nucleus Detect, might be worth its $3,980 price tag. Blood tests for cancer, known as liquid biopsies, have become available in recent years to guide treatments for people already diagnosed. But how useful are they?

Guide 81

Guide Study San Diego Journal 81

socalTECH

SEPTEMBER 27, 2012

In a proof that it's not all social media and e-commerce here in Southern California, number two ranking startup in The Wall Street Journal's ranking of the "Top 50 Startups" is none other than wireless hardware provider Xirrus , based in Thousand Oaks. That list included Laguna Hills-based Glaukos at number 7; Donuts Inc. , READ MORE>>.

West Hollywood 145

West Hollywood Thousand Oaks Southern California Journal 145

socalTECH

MARCH 18, 2011

San Diego-based Websense is reportedly considering a sale of the company, according to a report this week in the Wall Street Journal. The Journal reports Websense has hired investment banking firm Qatalyst Partners on the sale. According to the WSJ, the firm is looking to get around $1B for the company.

Report 145

Report Journal San Diego Sales 145

Xconomy

JULY 6, 2018

More details from two drug programs up for approval this year to treat a rare genetic disease emerged yesterday, published in side-by-side papers in the New England Journal of Medicine. An accompanying editorial in the journal praises the drugs for hitting their goals in the “landmark” trials.

Journal 49

Journal San Diego Research Pricing 49

socalTECH

JANUARY 11, 2012

The company said the redesign came after finding that users were interested in using its tools to create blog-like travel and trip journals, rather than the original, animated slideshows the tool provided. READ MORE>>.

Blogging 154

Blogging eHarmony Journal Seed Funding 154

socalTECH

JUNE 28, 2011

San Diego-based SweetLabs , the firm formerly known as OpenCandy, is taking on the mobile app model, and applying it to the desktop. The firm said today that it has launched a beta of Pokki , a platform which lets web developers create desktop apps, using languages such as HTML5, CSS, and JavaScript.

JavaScript 157

JavaScript Journal San Diego Web Development 157

socalTECH

MARCH 3, 2011

The Wall Street Journal, at a conference in Santa Barbara this week, named its list of "Top 10" clean technology firms, naming two local companies to the list of firms with the "greatest potential to succeed."

Santa Barbara 140

Santa Barbara Technology Idealab Burbank 140

Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson. .

News 57

News San Diego Journal Technical Review 57

Xconomy

JULY 26, 2016

Adding to the confusion, the most-recent MoneyTree Report on San Diego venture capital activity shows that Ostendo raised almost $10 million in VC funding during the second quarter. The Journal also reported at the time that Ostendo had raised $90 million from venture capital firms and Pieter Thiel, the investor and PayPal co-founder.

Technology 40

Technology Venture Capital Beverly Hills Funding 40

L.A. Business Journal

DECEMBER 20, 2016

has been awarded a contract for part of the decommissioning process of the shuttered San Onofre nuclear generating station in northern San Diego County. A joint venture team including L.A.’s s Aecom Technology Corp.

San Diego 100

San Diego Technology 100

Xconomy

JUNE 12, 2018

He’s the CEO of San Diego medical device startup Tear Film Innovations, which recently raised a. Come to think of it, do your eyes feel dry? Some eye doctors are finding more cases of dry eye in young adults, and even children. That has Rob Thornill seeing opportunity. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 71

San Diego Social Media Media Startup 71

Xconomy

MAY 24, 2018

The research, published in the journal Cell , indicate that several specific strains of bacteria work together in mice to provide neuroprotective effects against epileptic seizures.

Journal 76

Journal UCLA Class Research 76

socalTECH

MAY 7, 2010

However, it's a very large market--we peg it at around $11 billion a year, and some estimate it to be as big as $20 billion a year, including scientific journals, academic journals, scientific societies, and conferences. It's largely a publishing market, and has been around for hundreds of years. You can see that on the SciVee site.

Journal 124

Journal Technical Review UCSD Web 124

Xconomy

OCTOBER 25, 2017

A new paper from the researchers, published this month in the journal Alzheimer’s & Dementia , is on one level a reminder of decades of research on the cholinergic system—neurons that produce a signaling chemical called acetylcholine.

Research 78

Research Journal San Diego Blogging 78

Xconomy

FEBRUARY 5, 2018

When those investors do open their wallets, they’re shunning risky investments in favor of what the Wall Street Journal called “the upper echelon of highly valued startups” such as Airbnb and WeWork. You could make a good case that these investors are taking the “venture” out of “venture capital.”

Angel 66

Angel Entrepreneur Journal Venture Capital 66

Xconomy

AUGUST 17, 2016

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.

Invest 40

Invest San Diego Journal Technical Review 40

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

SEPTEMBER 7, 2016

San Diego-based Retrophin said that its drug, sparsentan, outperformed another drug sometimes used to manage a rare kidney disease, called focal segmental glomerulosclerosis (FSGS), in a Phase 2 clinical trial. He licensed the drug from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) in March 2012. on the Nasdaq.

San Diego 40

San Diego Pricing Study Journal 40

Xconomy

OCTOBER 7, 2016

—Meanwhile, in the wake of the Mylan hearings, the Wall Street Journal this week was the latest outlet to record the animosity between drugmakers and pharmacy benefit managers , the middlemen who buy drugs in bulk for large employers and other insurance payers. . With some caveats, ICER recommended lower prices.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Tech.Co

NOVEMBER 28, 2017

Milwaukee County Executive Chris Abele and Oscar-winning filmmaker John Ridley confirmed their plans in a recent joint statement to the Journal Sentinel , but haven’t explained much else about the incubator, which could help along the (relatively) under-explored film startup niche if completed. Brooklyn Foodworks.

Incubator 70

Incubator Santa Clarita Technical Advisors FAQ 70

Xconomy

JUNE 3, 2016

—A team led by Jef Boeke of New York University, George Church of Harvard University, Andrew Hessel of software maker Autodesk, and Nancy Kelley proposed in the journal Science to build a synthetic human genome. billion acquisition of San Diego’s Auspex Pharmaceuticals last year.

San Diego 62

San Diego Patents Acquisition News 62

Xconomy

AUGUST 16, 2016

A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Product 40

Product Journal Venture Capital Demand 40

Xconomy

AUGUST 30, 2016

My advice: write down your passwords in a journal and keep it in a secure location at home, such as a safe. The majority of people think of one clever password, and, in fear that they won’t be able to remember multiple passwords, they end up using it for all their accounts. Before you go, update software on all devices.

Journal 64

Journal Social Media Tips Writing 64

Xconomy

AUGUST 5, 2016

The Wall Street Journal reported that Cambridge, MA-based Biogen (NASDAQ: BIIB ) has drawn interest from the likes of Merck (NYSE: MRK ) and Allergan (NYSE: AGN ) as a possible takeover target. —Meanwhile, scientists from San Diego-based Synthetic Genomics and the J.

News 40

News Thousand Oaks Pricing Report 40

Xconomy

JULY 8, 2016

British medical journal The Lancet published a study , funded by the Bill and Melinda Gates Foundation, that showed viral hepatitis has become the seventh leading cause of death globally, up from tenth in 1990. —Another health scourge was in the news: hepatitis.

News 52

News Pricing Journal Startup 52

Xconomy

AUGUST 9, 2016

According to the Wall Street Journal, PFWTMs (“people familiar with the matter”) say the new device will look pretty much the same as the iPhone 6s. Apple’s iPhone 7 is due out next month. The biggest change: no more headphone plug.

Software Review 40

Software Review Screening Design Mobile 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Mark Holtzman for The Wall Street Journal. Mark Holtzman for The Wall Street Journal). edition of The Wall Street Journal, with the headline: Tech Titans Hit the Beach. Downtown San Diego Condos. Journal Community. MarketWatch. MarketWatch. AllThingsDigital.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

JULY 17, 2020

If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

Venture Capital 90

Venture Capital Invest Research Capital 90

Xconomy

APRIL 15, 2019

If a once-modest regional hospital and its new biotech allies have their way, the capital of Ohio could one day rival America’s other biomedical hubs. Our goal is to make Columbus the center of the universe for gene therapy,” says Doug Ingram, CEO of Sarepta Therapeutics.

Capital 111

Capital Startup San Diego Journal 111

Xconomy

AUGUST 19, 2016

Meanwhile, the latest study reporting that the drugs’ $14,000-a-year list price isn’t cost effective, published this week in the Journal of the American Medical Association , has the drugs’ owners, Amgen (NASDAQ: AMGN ) and Regeneron Pharmaceuticals (NASDAQ: REGN ), up in arms.

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

NOVEMBER 26, 2018

Going deeper into the new world of genetic medicine, the FDA has for the second time approved a drug that targets a tumor’s DNA fingerprint, no matter where in the body that cancer is found. And more could be on the way.

Design 110

Design San Diego Journal Blogging 110

socalTECH

FEBRUARY 23, 2009

San Diego-based Newsforce (www.newsforce.com) is a startup which is looking to take advantage of the hunger of the newspaper and media business for revenue, and has created a product which takes press releases and commercial content, and inserts them onto news sites in "sponsored content" blocks. Have you had any issues with that here?

News 124

News Advertising Press Sites 124

Xconomy

JUNE 30, 2016

Springer isn’t disclosing Morphic’s discoveries, and the company has yet to publish research in peer-reviewed journals about its work. Thanks in part to better structural biology tools, says Springer, “we think we understand the problem.” ” That’s yet to be proven.

Startup 40

Startup Invest Journal Research 40

Xconomy

AUGUST 12, 2016

—The status of Sarepta Therapeutics’ (NASDAQ: SRPT ) Duchenne muscular dystrophy drug eteplirsen remains in regulatory limbo, and the Wall Street Journal published this editorial speculating that a “differing-professional-opinions” proceeding—how the FDA clears up internal scientific disputes—might be holding it up.

Google 40

Google Technical Review News Research 40

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

MAY 7, 2019

The American Academy of Neurology meeting in Philadelphia is rolling on through the end of this week. There has been plenty of news to digest already. New clinical data could herald cutting-edge treatments for migraine, the rare disease spinal muscular atrophy, the deadly neurological disorder amyotrophic lateral sclerosis, and more.

News 77

News Conference San Diego Journal 77

Xconomy

MARCH 17, 2017

Stung by slow sales of its next-generation anti-cholesterol drug, Amgen hopes new clinical data, released this morning, will spur doctors to boost prescriptions and—perhaps more important—drive insurers to loosen their restrictions. political issue, and pricey new cholesterol drugs have been a key battleground.

Study 87

Study Pricing Sales Journal 87